Optogenetic neuromodulation

Neurosurgery

Volumn 64, Issue 5, 2009, Pages 796-804

  Henderson, Jaimie M ^a,c   Federici, Thais ^b   Boulis, Nicholas ^b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Gene therapy; Neuromodulation; Optogenetics; Viral vector

Indexed keywords

ADENOVIRUS VECTOR; PROENKEPHALIN; VIRUS VECTOR; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; GLASS FIBER;

ACCURACY; ALZHEIMER DISEASE; BRAIN REGION; CELL POPULATION; CHRONIC PAIN; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONFERENCE PAPER; DEPRESSION; DRUG FATALITY; ELECTRIC FIELD; ELECTROSTIMULATION; EPILEPSY; GENE DELIVERY SYSTEM; HUMAN; INFLAMMATION; LEUKEMIA; NERVE CELL; NERVE CELL INHIBITION; NERVE CELL NETWORK; NERVE CONDUCTION; NERVE STIMULATION; NERVOUS SYSTEM; NEUROLOGIC DISEASE; NEUROMODULATION; OBSESSIVE COMPULSIVE DISORDER; OPTOGENETIC NEUROMODULATION; PHOTOSENSITIVITY; PRIORITY JOURNAL; SCHIZOPHRENIA; STIMULATION; TARGET CELL; TEMPORAL CORTEX; ANIMAL; BIOLOGICAL MODEL; BIOTECHNOLOGY; CYTOLOGY; FIBER OPTICS; GENETICS; INSTRUMENTATION; METABOLISM; METHODOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; BIOTECHNOLOGY; ELECTRIC STIMULATION; FIBER OPTIC TECHNOLOGY; HUMANS; MODELS, BIOLOGICAL; NERVOUS SYSTEM; NEURONS; NEUROTRANSMITTER AGENTS; OPTICAL FIBERS;

EID: 67650739414     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000339171.87593.6A     Document Type: Conference Paper

References (50)

1. Aravanis AM, Wang LP, Zhang F, Meltzer LA, Mogri MZ, Schneider MB, Deisseroth K: An optical neural interface: In vivo control of rodent motor cortex with integrated fiberoptic and optogenetic technology. J Neural Eng 4:S143-S156, 2007.
2. Arenkiel BR, Peca J, Davison IG, Feliciano C, Deisseroth K, Augustine GJ, Ehlers MD, Feng G: In vivo light- induced activation of neural circuitry in transgenic mice expressing channelrhodopsin-2. Neuron 54:205-218, 2007.
3. Banghart M, Borges K, Isacoff E, Trauner D, Kramer RH: Light- activated ion channels for remote control of neuronal firing. Nat Neurosci 7:1381-1386, 2004.
4. Benítez JA, Segovia J: Gene therapy targeting in the central nervous system. Curr Gene Ther 3:127-145, 2003.
5. Boyden ES, Zhang F, Bamberg E, Nagel G, Deisseroth K: Millisecond-timescale, genetically targeted optical control of neural activity. Nat Neurosci 8:1263-1268, 2005.
6. Burger C, Gorbatyuk OS, Velardo MJ, Peden CS, Williams P, Zolotukhin S, Reier PJ, Mandel RJ, Muzyczka N: Recombinant AAV viral vectors pseudo-typed with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther 10:302-317, 2004.
7. Callaway EM: Caged neurotransmitters. Shedding light on neural circuits. Curr Biol 4:1010-1012, 1994.
8. Callaway EM: A molecular and genetic arsenal for systems neuroscience. Trends Neurosci 28:196-201, 2005.
9. Callaway EM, Katz LC: Photostimulation using caged glutamate reveals functional circuitry in living brain slices. Proc Natl Acad Sci U S A 90:7661-7665, 1993.
10. B receptors in the basal ganglia in monkeys. Neuroscience 95:127-140, 2000.
11. Denk W: Two- photon scanning photochemical microscopy: Mapping ligand-gated ion channel distributions. Proc Natl Acad Sci U S A 91:6629-6633, 1994.
12. During MJ, Kaplitt MG, Stern MB, Eidelberg D: Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. Hum Gene Ther 12:1589-1591, 2001.
13. Farber IC, Grinvald A: Identification of presynaptic neurons by laser photo-stimulation. Science 222:1025-1027, 1983.
14. Forsayeth JR, Eberling JL, Sanftner LM, Zhen Z, Pivirotto P, Bringas J, Cunningham J, Bankiewicz KS: A dose- ranging study of AAV- hAADC therapy in Parkinsonian monkeys. Mol Ther 14:571-577, 2006.
15. Girod A, Ried M, Wobus C, Lahm H, Leike K, Kleinschmidt J, Deléage G, Hallek M: Genetic capsid modifications allow efficient re- targeting of adeno-associated virus type 2. Nat Med 5:1052-1057, 1999.
16. Goss JR, Mata M, Goins WF, Wu HH, Glorioso JC, Fink DJ: Antinociceptive effect of a genomic herpes simplex virus- based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Ther 8:551-556, 2001.
17. Gradinaru V, Thompson KR, Deisseroth K: eNpHR: A Natronomonas halorhodopsin enhanced for optogenetic applications. Brain Cell Biol 36:129-139, 2008.
18. Hacein- Bey- Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, Lim A, Osborne CS, Pawliuk R, Morillon E, Sorensen R, Forster A, Fraser P, Cohen JI, de Saint Basile G, Alexander I, Wintergerst U, Frebourg T, Aurias A, Stoppa- Lyonnet D, Romana S, Radford- Weiss I, Gross F, Valensi F, Delabesse E, Macintyre E, Sigaux F, Soulier J, Leiva LE, Wissler M, Prinz C, Rabbitts TH, Le Deist F, Fischer A, Cavazzana- Calvo M: LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID- X1. Science 302:415-419, 2003.
19. Hegemann P, Oesterbelt D, Steiner M: The photocycle of the chloride pump halorhodopsin. I: Azide- catalyzed deprotonation of the chromophore is a side reaction of photocycle intermediates inactivating the pump. EMBO J 4:2347-2350, 1985.
20. Ishizuka T, Kakuda M, Araki R, Yawo H: Kinetic evaluation of photosensitivity in genetically engineered neurons expressing green algae light- gated channels. Neurosci Res 54:85-94, 2006.
21. Johns DC, Marx R, Mains RE, O'Rourke B, Marbán E: Inducible genetic suppression of neuronal excitability J Neurosci 19:1691-1697, 1999.
22. Kalaidzidis IV, Kalaidzidis YL, Kaulen AD: Flash- induced voltage changes in halorhodopsin from Natronobacterium pharaonis. FEBS Lett 427:59-63, 1998.
23. Kane K, Taub A: A history of local electrical analgesia. Pain 1:125-138, 1975.
24. Kaplitt MG, Feigin A, Tang C, Fitzsimons HL, Mattis P, Lawlor PA, Bland RJ, Young D, Strybing K, Eidelberg D, During MJ: Safety and tolerability of gene therapy with an adeno- associated virus (AAV) borne GAD gene for Parkinson's disease: An open label, phase I trial. Lancet 369:2097-2105, 2007.
25. Katz LC, Dalva MB: Scanning laser photostimulation: A new approach for analyzing brain circuits. J Neurosci Methods 54:205-218, 1994.
26. Li X, Gutierrez DV, Hanson MG, Han J, Mark MD, Chiel H, Hegemann P, Landmesser LT, Herlitze S: Fast noninvasive activation and inhibition of neural and network activity by vertebrate rhodopsin and green algae channel-rhodopsin. Proc Natl Acad Sci U S A 102:17816-17821, 2005.
27. Lima SQ, Miesenböck G: Remote control of behavior through genetically targeted photostimulation of neurons. Cell 121:141-152, 2005.
28. Marks WJ Jr, Ostrem JL, Verhagen L, Starr PA, Larson PS, Bakay RA, Taylor R, Cahn- Weiner DA, Stoessl AJ, Olanow CW, Bartus RT: Safety and tolerability of intraputaminal delivery of CERE-120 (adeno- associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: An open- label, phase I trial. Lancet Neurol 7:400-408, 2008.
29. Marshall E: Gene therapy death prompts review of adenovirus vector. Science 286:2244-2245, 1999.
30. Mazzone P, Lozano AM, Stanzione P, Galati S, Scarnati E, Peppe A, Stefani A: Implantation of human pedunculopontine nucleus: A safe and clinically relevant target in Parkinson's disease. NeuroReport 16:1877-1881, 2005.
31. Medtronic: Soletra™ Neurostimulator for Deep Brain Stimulation, Model 7246, Physician and Hospital Staff Manual. Minneapolis, Medtronic, 2003.
32. Nagel G, Szellas T, Huhn W, Kateriya S, Adeishvili N, Berthold P, Ollig D, Hegemann P, Bamberg E: Channelrhodopsin-2, a directly light- gated cation-selective membrane channel. Proc Natl Acad Sci U S A 100:13940-13945, 2003.
33. Nerbonne JM: Caged compounds: Tools for illuminating neuronal responses and connections. Curr Opin Neurobiol 6:379-386, 1996.
34. Peel AL, Zolotukhin S, Schrimsher GW, Muzyczka N, Reier PJ: Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type- specific promoters. Gene Ther 4:16-24, 1997.
35. Petreanu L, Huber D, Sobczyk A, Svoboda K: Channelrhodopsin-2-assisted circuit mapping of long- range callosal projections. Nat Neurosci 10:663-668, 2007.
36. Rossi U: The history of electrical stimulation of the nervous system for the control of pain, in Simpson BA (ed): Electrical Stimulation and the Relief of Pain. Amsterdam, Elsevier, 2003, pp 5-16.
37. Sánchez- Pernaute R, Harvey- White J, Cunningham J, Bankiewicz KS: Functional effect of adeno- associated virus mediated gene transfer of aromatic L- amino acid decarboxylase into the striatum of 6- OHDA- lesioned rats. Mol Ther 4:324-330, 2001.
38. Shevtsova Z, Malik JM, Michel U, Bähr M, Kügler S: Promoters and serotypes: Targeting of adeno- associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo. Exp Physiol 90:53-59, 2005.
39. Shi W, Arnold GS, Bartlett JS: Insertional mutagenesis of the adeno- associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors. Hum Gene Ther 12:1697-1711, 2001.
40. Smith Y, Parent A: Neurons of the subthalamic nucleus in primates display glutamate but not GABA immunoreactivity. Brain Res 453:353-356, 1988.
41. Smith RL, Traul DL, Schaack J, Clayton GH, Staley KJ, Wilcox CL: Characterization of promoter function and cell- type- specific expression from viral vectors in the nervous system. J Virol 74:11254-11261, 2000.
42. Stefani A, Lozano AM, Peppe A, Stanzione P, Galati S, Tropepi D, Pierantozzi M, Brusa L, Scarnati E, Mazzone P: Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain 130:1596-1607, 2007.
43. Teng Q, Tanase D, Tanase DK, Liu JK, Garrity- Moses ME, Baker KB, Boulis NM: Adenoviral clostridial light chain gene- based synaptic inhibition through neuronal synaptobrevin elimination. Gene Ther 12:108-119, 2005.
44. Wang H, Peca J, Matsuzaki M, Matsuzaki K, Noguchi J, Qiu L, Wang D, Zhang F, Boyden E, Deisseroth K, Kasai H, Hall WC, Feng G, Augustine GJ: High- speed mapping of synaptic connectivity using photostimulation in channelrhodopsin-2 transgenic mice. Proc Natl Acad Sci U S A 104:8143-8148, 2007.
45. Wieboldt R, Ramesh D, Carpenter BK, Hess GP: Synthesis and photochemistry of photolabile derivatives of γ-aminobutyric acid for chemical kinetic investigations of the gamma- aminobutyric acid receptor in the millisecond time region. Biochemistry 33:1526-1533, 1994.
46. Yang J, Teng Q, Federici T, Najm I, Chabardes S, Moffitt M, Alexopoulos A, Riley J, Boulis NM: Viral clostridial light chain gene- based control of penicillin-induced neocortical seizures. Mol Ther 15:542-551, 2007.
47. Zemelman BV, Lee GA, Ng M, Miesenböck G: Selective photostimulation of genetically chARGed neurons. Neuron 33:15-22, 2002.
48. Zhang F, Wang LP, Boyden ES, Deisseroth K: Channelrhodopsin-2 and optical control of excitable cells. Nat Methods 3:785-792, 2006.
49. Zhang F, Wang LP, Brauner M, Liewald JF, Kay K, Watzke N, Wood PG, Bamberg E, Nagel G, Gottschalk A, Deisseroth K: Multimodal fast optical interrogation of neural circuitry. Nature 446:633-639, 2007.
50. Zhao Z, Krishnaney A, Teng Q, Yang J, Garrity- Moses M, Liu JK, Venkiteswaran K, Subramanian T, Davis M, Boulis NM: Anatomically discrete functional effects of adenoviral clostridial light chain gene- based synaptic inhibition in the midbrain. Gene Ther 13:942-952, 2006.